A dedicated Fracture Liaison Service telephone program and use of bone turnover markers for evaluating 1-year persistence with oral bisphosphonates
Crossref DOI link: https://doi.org/10.1007/s00198-017-4340-5
Published Online: 2017-12-19
Published Print: 2018-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
van den Berg, P. http://orcid.org/0000-0002-3791-5816
van Haard, P. M. M.
van der Veer, E.
Geusens, P. P.
van den Bergh, J. P.
Schweitzer, D. H.
Funding for this research was provided by:
Novartis (10.000 euro)
License valid from 2017-12-19